Encompass Health Corp (NYSE:EHC)
$ 102.94 0.1 (0.1%) Market Cap: 10.37 Bil Enterprise Value: 13.01 Bil PE Ratio: 24.86 PB Ratio: 5.30 GF Score: 82/100

Encompass Health Corp at Barclays Global Healthcare Conference Transcript

Mar 15, 2023 / 01:00PM GMT
Release Date Price: $52.06 (-1.85%)
Steven James Valiquette
Barclays Bank PLC, Research Division - Research Analyst

All right. Great. Welcome to Day 2 of the Barclays Healthcare Conference. I'm Steven Valiquette, the healthcare services analyst. Going to kick things off with Encompass this morning for this session, we have Mark Tarr, the company's CEO; and also Doug Coltharp, the CFO of the company. And we have Mark Miller from Investor Relations in the audience here as well. This will be a fireside chat. So I guess we'll just dive right in.

Unidentified Company Representative

Perfect.

Questions & Answers

Steven James Valiquette
Barclays Bank PLC, Research Division - Research Analyst

All right. Great. So maybe to start with kind of talking about some of the key growth drivers for the company. I think for '22 to '26, you guys talked about 6 to 10 de novo openings per year. On top of that, adding now 80 to 120 net additions per year to existing facilities and having all that culminate in a 6% to 8% discharge CAGR.

So I guess when thinking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot